Duration vs Discipline: Uncovering Therapy Adherence Antiretrovirals in People with HIV

Background: HIV is a retrovirus targeting the immune system, requiring continuous antiretro-viral therapy (ARVs) for effective management. In Indonesia, 329,581 HIV cases were documented from 1987 to 2022, with only 51% receiving ARVs. Adherence is crucial for treatment success, but prolonged therapy may impact medication compliance. This study investigates the correlation between ARV treatment duration and adherence levels at Dr. Moewardi Hospital. Subjects and Method: A cross-sectional observational study was conducted at the Voluntary Counseling and Testing (VCT) clinic, involving 60 HIV-diagnosed individuals selected through purposive sampling. Therapy duration was extracted from medical records, and adherence was assessed using the MMAS-8 questionnaire during June and July 2024. Bivariate analysis employed the Spearman correlation coefficient test. Results: The study sample predominantly consisted of individuals aged 36-45 years, with the majority having completed high school education. The mean therapy duration was 5.60 ± 3.64 years, ranging from 1 to 15 years. Adherence levels varied significantly, with 48.3% of patients demonstrating high adherence, characterized by a mean therapy duration (Mean= 6.86 years; SD= 3.62). Moderate adherence was observed in 16.7% of participants, with a mean therapy duration (Mean= 6.60 years; SD= 2.55). Low adherence was found in 35.0% of patients, associated with a shorter mean therapy duration (Mean= 3.38 years; SD= 3.14). There was a positive and sig¬nificant association between therapy duration and adherence level (r= 0.415; p= 0.001). Conclusion: The length of antiretroviral therapy (ART) exhibits a favorable correlation with adherence levels among individuals living with HIV. An extended duration of the therapeutic regimen is correlated with an enhanced adherence rate. This observation underscores the significance of sustained support, particularly during the initial years of the treatment course.

Authors

Institutions

Publication Details

Journal
Indonesian Journal of Medicine
Published
2025-01-10
DOI
https://doi.org/10.26911/theijmed.v10i1.803
Primary Topic
HIV/AIDS Research and Interventions
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Duration vs Discipline: Uncovering Therapy Adherence Antiretrovirals in People with HIV

Desy Puspa Putri, Evi Nurhayatun, Yusuf Vindra Asmara
Indonesian Journal of Medicine
HIV/AIDS Research and Interventions
article

Duration vs Discipline: Uncovering Therapy Adherence Antiretrovirals in People with HIV

Desy Puspa Putri, Evi Nurhayatun, Yusuf Vindra Asmara
article en

Abstract

Background: HIV is a retrovirus targeting the immune system, requiring continuous antiretro-viral therapy (ARVs) for effective management. In Indonesia, 329,581 HIV cases were documented from 1987 to 2022, with only 51% receiving ARVs. Adherence is crucial for treatment success, but prolonged therapy may impact medication compliance. This study investigates the correlation between ARV treatment duration and adherence levels at Dr. Moewardi Hospital. Subjects and Method: A cross-sectional observational study was conducted at the Voluntary Counseling and Testing (VCT) clinic, involving 60 HIV-diagnosed individuals selected through purposive sampling. Therapy duration was extracted from medical records, and adherence was assessed using the MMAS-8 questionnaire during June and July 2024. Bivariate analysis employed the Spearman correlation coefficient test. Results: The study sample predominantly consisted of individuals aged 36-45 years, with the majority having completed high school education. The mean therapy duration was 5.60 ± 3.64 years, ranging from 1 to 15 years. Adherence levels varied significantly, with 48.3% of patients demonstrating high adherence, characterized by a mean therapy duration (Mean= 6.86 years; SD= 3.62). Moderate adherence was observed in 16.7% of participants, with a mean therapy duration (Mean= 6.60 years; SD= 2.55). Low adherence was found in 35.0% of patients, associated with a shorter mean therapy duration (Mean= 3.38 years; SD= 3.14). There was a positive and sig¬nificant association between therapy duration and adherence level (r= 0.415; p= 0.001). Conclusion: The length of antiretroviral therapy (ART) exhibits a favorable correlation with adherence levels among individuals living with HIV. An extended duration of the therapeutic regimen is correlated with an enhanced adherence rate. This observation underscores the significance of sustained support, particularly during the initial years of the treatment course.

Indonesian Journal of MedicineVol. 10(1)
Sebelas Maret University (ID)
Openalex Percentile: Top 89%
HIV/AIDS Research and Interventions
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Duration vs Discipline: Uncovering Therapy Adherence Antiretrovirals in People with HIV — Desy Puspa Putri, Evi Nurhayatun, et al. · Indonesian Journal of Medicine (2025) | TGRS Research Map | TGRS